These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2519031)

  • 1. Gastric mucosal lesion in liver disease: impaired gastric mucosal defence mechanism in rats with induced liver injury and in patients with liver cirrhosis.
    Tomoda J; Mizuno M; Sugihara T; Itano T; Tsuji T
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():136-9. PubMed ID: 2519031
    [No Abstract]   [Full Text] [Related]  

  • 2. Expression of a 72-kDa heat shock protein, and its cytoprotective function, in gastric mucosa in cirrhotic rats.
    Watanabe D; Otaka M; Mikami K; Yoneyama K; Goto T; Miura K; Ohshima S; Lin JG; Shibuya T; Segawa D; Kataoka E; Konishi N; Odashima M; Sugawara M; Watanabe S
    J Gastroenterol; 2004 Aug; 39(8):724-33. PubMed ID: 15338365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Portal hypertensive gastropathy].
    Tao XH
    Zhonghua Gan Zang Bing Za Zhi; 2009 Apr; 17(4):254-6. PubMed ID: 19403020
    [No Abstract]   [Full Text] [Related]  

  • 4. Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72.
    Mikami K; Otaka M; Watanabe D; Goto T; Endoh A; Miura K; Ohshima S; Yoneyama K; Sato M; Shibuya T; Segawa D; Kataoka E; Yoshino R; Takeuchi S; Sato W; Odashima M; Watanabe S
    J Gastroenterol Hepatol; 2006 Nov; 21(11):1669-74. PubMed ID: 16984587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastrointestinal lesions in liver cirrhosis].
    Fujiwara Y; Arakawa T; Higuchi K; Kuroki T
    Nihon Rinsho; 1998 Sep; 56(9):2387-90. PubMed ID: 9780725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats.
    Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG
    Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The stomach in cirrhosis. The legend of Proteus retold.
    Lingenfelser T; Krige JE
    J Clin Gastroenterol; 1993 Sep; 17(2):92-6. PubMed ID: 8409328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Causative relationship between a hyperdynamic state due to increased A-V anastomoses in the gastric wall and AGML in patients with liver cirrhosis.
    Hasumi A; Aoki H; Shimazu M; Kawata S; Yoshimatsu Y
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():143-5. PubMed ID: 2519033
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes in mucosal and vascular bed in various parts of gastrointestinal tract in patients with liver cirrhosis with portal hypertension].
    Sidorova IO
    Eksp Klin Gastroenterol; 2012; (6):115-22. PubMed ID: 23402201
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of injury of gastric parietal vessels by immunocomplexes in the mechanism of gastric mucosal lesion in portal hypertension with cirrhosis.
    Mba Mba C; Yang Z
    J Tongji Med Univ; 1997; 17(1):44-8. PubMed ID: 9639785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of the gastric microcirculation.
    Vigneri S; Scialabba A; Termini R; Germanà B; Vianello F; Grassi SA; Plebani M; Di Mario F
    Ital J Gastroenterol; 1992 Jan; 24(1):22-30. PubMed ID: 1571576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Underlying mechanism of portal hypertensive gastropathy in cirrhosis: a hemodynamic and morphological approach.
    Curvêlo LA; Brabosa W; Rhor R; Lanzoni V; Parise ER; Ferrari AP; Kondo M
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1541-6. PubMed ID: 19743998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protective effect of vitamin E on gastric mucosal injury in rats with cirrhosis of the liver.
    Cantürk NZ; Cantürk Z; Utkan NZ; Yenisey C; Ozbilim G; Gelen T; Yalman Y
    Chin Med J (Engl); 1999 Jan; 112(1):56-60. PubMed ID: 11593643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the incidence and significance of the "mosaic pattern" in patients with cirrhosis, noncirrhotic portal fibrosis, and extrahepatic obstruction.
    Sarin SK; Misra SP; Singal A; Thorat V; Broor SL
    Am J Gastroenterol; 1988 Nov; 83(11):1235-9. PubMed ID: 3263791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity of gastric mucosal nitric oxide synthase in portal hypertensive gastropathy.
    El-Newihi HM; Kanji VK; Mihas AA
    Am J Gastroenterol; 1996 Mar; 91(3):535-8. PubMed ID: 8633504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward a more realistic animal model for the study of portal hypertensive gastropathy.
    Kotzampassi K; Eleftheriadis E
    Am J Gastroenterol; 1994 Aug; 89(8):1272-3. PubMed ID: 8053458
    [No Abstract]   [Full Text] [Related]  

  • 17. Study of the relationship between portal hypertension and gastroduodenal mucosal lesions.
    Mitani S; Yoshida J; Saitoh M; Asaka M; Matsushima T; Miyazaki T
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():146-50. PubMed ID: 2519034
    [No Abstract]   [Full Text] [Related]  

  • 18. Gastric mucosal blood flow in portal hypertension, gastropathy and sclerotherapy.
    Triger DR; Walsh JT; Smart HL
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():94-5. PubMed ID: 2519099
    [No Abstract]   [Full Text] [Related]  

  • 19. Endoscopic, histologic and haemodynamic studies on portal hypertensive gastric mucosa.
    Toyonaga A; Iwao T; Shimotsuura Y; Tanikawa K
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():132-5. PubMed ID: 2519030
    [No Abstract]   [Full Text] [Related]  

  • 20. [Portal hypertensive gastropathy].
    Brinch K; Møller S; Henriksen JH; Becker PU
    Ugeskr Laeger; 1995 Nov; 157(46):6421-5. PubMed ID: 7483098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.